The serum concentration of Pantoprazole can be increased when it is combined with Fosaprepitant. The serum concentration of Pantoprazole can be increased when it is combined with Osimertinib. The serum concentration of Pantoprazole can be decreased when it is combined with Lumacaftor. The metabolism of Teniposide can be decreased when combined with Pantoprazole. The metabolism of Flutamide can be decreased when combined with Pantoprazole. The serum concentration of Posaconazole can be decreased when it is combined with Pantoprazole. The metabolism of Moclobemide can be decreased when combined with Pantoprazole. The serum concentration of Pantoprazole can be decreased when it is combined with Siltuximab. The serum concentration of Rifaximin can be increased when it is combined with Pantoprazole. The metabolism of Doxepin can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Lopinavir. The serum concentration of Saquinavir can be increased when it is combined with Pantoprazole. The metabolism of Glucosamine can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be increased when combined with Primidone. The serum concentration of Conivaptan can be increased when it is combined with Pantoprazole. The serum concentration of Mycophenolic acid can be decreased when it is combined with Pantoprazole. The serum concentration of Pantoprazole can be increased when it is combined with Ivacaftor. The metabolism of Pantoprazole can be decreased when combined with Efavirenz. The metabolism of Pantoprazole can be increased when combined with Rifampicin. The metabolism of Pantoprazole can be decreased when combined with Doxycycline. The metabolism of Pentamidine can be decreased when combined with Pantoprazole. The serum concentration of Pantoprazole can be decreased when it is combined with Enzalutamide. Pantoprazole can cause a decrease in the absorption of Ferric pyrophosphate resulting in a reduced serum concentration and potentially a decrease in efficacy. The metabolism of Pantoprazole can be decreased when combined with Telaprevir. The metabolism of Thioridazine can be decreased when combined with Pantoprazole. The metabolism of Dexlansoprazole can be decreased when combined with Pantoprazole. The metabolism of Imipramine can be decreased when combined with Pantoprazole. The metabolism of Axitinib can be decreased when combined with Pantoprazole. The metabolism of Rosuvastatin can be decreased when combined with Pantoprazole. The serum concentration of Tacrolimus can be increased when it is combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Crizotinib. The metabolism of Lapatinib can be decreased when combined with Pantoprazole. The metabolism of Methsuximide can be decreased when combined with Pantoprazole. The serum concentration of Pantoprazole can be increased when it is combined with Simeprevir. The metabolism of Pantoprazole can be increased when combined with Rifabutin. The serum concentration of Pantoprazole can be decreased when it is combined with Mitotane. The metabolism of Cyclophosphamide can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Topiramate. The metabolism of Dapsone can be decreased when combined with Pantoprazole. The therapeutic efficacy of Ibandronate can be decreased when used in combination with Pantoprazole. The metabolism of Bromazepam can be decreased when combined with Pantoprazole. The serum concentration of Nilotinib can be decreased when it is combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Sildenafil. The therapeutic efficacy of Zoledronic acid can be decreased when used in combination with Pantoprazole. The metabolism of Promazine can be decreased when combined with Pantoprazole. The metabolism of Trimethadione can be decreased when combined with Pantoprazole. The metabolism of Brivaracetam can be decreased when combined with Pantoprazole. The metabolism of Levomilnacipran can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Fosamprenavir. The metabolism of Formoterol can be decreased when combined with Pantoprazole. The therapeutic efficacy of Pamidronate can be decreased when used in combination with Pantoprazole. The metabolism of Trabectedin can be decreased when combined with Pantoprazole. The metabolism of Clobazam can be decreased when combined with Pantoprazole. The metabolism of Progesterone can be decreased when combined with Pantoprazole. The serum concentration of Pantoprazole can be decreased when it is combined with St. John's Wort. The serum concentration of Ketoconazole can be decreased when it is combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Cyclosporine. The metabolism of Pantoprazole can be decreased when combined with Diltiazem. Pantoprazole can cause a decrease in the absorption of Ferric Citrate resulting in a reduced serum concentration and potentially a decrease in efficacy. The metabolism of Pantoprazole can be decreased when combined with Ropinirole. The therapeutic efficacy of Mesalazine can be decreased when used in combination with Pantoprazole. The metabolism of Escitalopram can be decreased when combined with Pantoprazole. Pantoprazole can cause a decrease in the absorption of Iron resulting in a reduced serum concentration and potentially a decrease in efficacy. The metabolism of Zidovudine can be decreased when combined with Pantoprazole. The serum concentration of Methotrexate can be increased when it is combined with Pantoprazole. The metabolism of Dopamine can be decreased when combined with Pantoprazole. The serum concentration of Rilpivirine can be decreased when it is combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Sulfisoxazole. The metabolism of Vortioxetine can be decreased when combined with Pantoprazole. The serum concentration of Pantoprazole can be decreased when it is combined with Tipranavir. The serum concentration of Pantoprazole can be increased when it is combined with Ceritinib. The metabolism of Dronabinol can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Bortezomib. The metabolism of Praziquantel can be decreased when combined with Pantoprazole. The serum concentration of Pantoprazole can be decreased when it is combined with Bosentan. The metabolism of Pantoprazole can be decreased when combined with Erythromycin. The metabolism of Cisapride can be decreased when combined with Pantoprazole. The serum concentration of Ranolazine can be increased when it is combined with Pantoprazole. The metabolism of Carbinoxamine can be decreased when combined with Pantoprazole. The metabolism of Tofacitinib can be decreased when combined with Pantoprazole. The metabolism of Flunitrazepam can be decreased when combined with Pantoprazole. The metabolism of Ibuprofen can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be increased when combined with Phenytoin. The metabolism of Timolol can be decreased when combined with Pantoprazole. The metabolism of Benzatropine can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Mexiletine. The metabolism of Diclofenac can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Modafinil. The metabolism of Quinine can be decreased when combined with Pantoprazole. The serum concentration of Pantoprazole can be increased when it is combined with Stiripentol. The metabolism of Ifosfamide can be decreased when combined with Pantoprazole. The metabolism of Aminophenazone can be decreased when combined with Pantoprazole. The serum concentration of Pantoprazole can be decreased when it is combined with Tocilizumab. The metabolism of Warfarin can be decreased when combined with Pantoprazole. The serum concentration of Aripiprazole can be decreased when it is combined with Pantoprazole. The serum concentration of the active metabolites of Nelfinavir can be reduced when Nelfinavir is used in combination with Pantoprazole resulting in a loss in efficacy. The metabolism of Pantoprazole can be decreased when combined with Lobeglitazone. The serum concentration of Raltegravir can be increased when it is combined with Pantoprazole. The metabolism of Tolbutamide can be decreased when combined with Pantoprazole. The serum concentration of Pantoprazole can be decreased when it is combined with Teriflunomide. The serum concentration of Pantoprazole can be increased when it is combined with Mifepristone. The metabolism of Guanfacine can be decreased when combined with Pantoprazole. The metabolism of Terbinafine can be decreased when combined with Pantoprazole. The metabolism of Azelastine can be decreased when combined with Pantoprazole. The metabolism of Thalidomide can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Cimetidine. The metabolism of Propofol can be decreased when combined with Pantoprazole. The metabolism of Tamoxifen can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Azithromycin. The metabolism of Ketobemidone can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Eslicarbazepine acetate. The metabolism of Pantoprazole can be decreased when combined with Dronedarone. The metabolism of Adinazolam can be decreased when combined with Pantoprazole. The serum concentration of Cilostazol can be increased when it is combined with Pantoprazole. Pantoprazole can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects. The serum concentration of Everolimus can be increased when it is combined with Pantoprazole. The metabolism of Pethidine can be decreased when combined with Pantoprazole. The serum concentration of Edoxaban can be increased when it is combined with Pantoprazole. The metabolism of Propranolol can be decreased when combined with Pantoprazole. The metabolism of Tapentadol can be decreased when combined with Pantoprazole. The therapeutic efficacy of Cysteamine can be decreased when used in combination with Pantoprazole. The metabolism of Fluoxetine can be decreased when combined with Pantoprazole. Pantoprazole can cause a decrease in the absorption of Iron saccharate resulting in a reduced serum concentration and potentially a decrease in efficacy. The serum concentration of Afatinib can be increased when it is combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Ticlopidine. The metabolism of Pantoprazole can be decreased when combined with Theophylline. The metabolism of Pipotiazine can be decreased when combined with Pantoprazole. The metabolism of Pantoprazole can be decreased when combined with Isoniazid. The serum concentration of Colchicine can be increased when it is combined with Pantoprazole. The metabolism of Pantoprazole can be increased when combined with Carbamazepine.